血液学炎症标志物对动脉瘤性蛛网膜下腔出血后迟发性脑缺血的预测价值
该回顾性观察研究纳入菲律宾最大教学医院6年间连续收治的222例动脉瘤性蛛网膜下腔出血患者,其中11.71%发生迟发性脑缺血。红细胞分布宽度对迟发性脑缺血有预测价值(AUC 0.70),中性粒细胞/淋巴细胞比值可能预测功能结局。
要点
- 222例中11.71%发生迟发性脑缺血。
- 红细胞分布宽度预测迟发性脑缺血AUC 0.70。
- 中性粒细胞/淋巴细胞比值可能预测功能结局AUC 0.67。
核心结论
- 部分血液学参数可能作为动脉瘤性蛛网膜下腔出血患者的预后生物标志物。
- 血液学生物标志物广泛可用且实用,在动脉瘤性蛛网膜下腔出血管理中可能具有临床价值,尤其在菲律宾等中低收入国家。
研究设计与样本
- 回顾性观察性6年病历审查,纳入菲律宾最大教学医院连续收治的222例动脉瘤性蛛网膜下腔出血患者。
主要发现
- 222例中11.71%发生迟发性脑缺血。
- 中性粒细胞/淋巴细胞比值≥5.9的患者多数 subsequently 死亡(77% vs 52%;P = 0.03)。
- 迟发性脑缺血与出院时改良Rankin量表评分3-6分的不良功能结局相关(92% vs 49%;P < 0.01),并与住院时间更长相关(中位数20天 vs 13天;P = 0.01)。
- 红细胞分布宽度预测迟发性脑缺血(AUC 0.70;95%CI 0.62-0.79;P < 0.01)。
- 中性粒细胞/淋巴细胞比值可能预测功能结局(AUC 0.67;95%CI 0.59-0.74)。
关键数值与推荐
- 红细胞分布宽度预测迟发性脑缺血AUC 0.70(95%CI 0.62-0.79;P < 0.01)。
- 中性粒细胞/淋巴细胞比值预测功能结局AUC 0.67(95%CI 0.59-0.74)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Our study aimed to determine the ability of hematologic markers (neutrophil/lymphocyte ratio [NLR], platelet/lymphocyte ratio, and red cell distribution width [RDW]) in predicting delayed cerebral ischemia (DCI), modified Rankin Scale scores, and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). METHODS: A retrospective observational 6-year review of medical records was conducted to identify all consecutive patients with aSAH admitted to the largest training hospital in the Philippines. Univariable and multivariable regression analyses were performed to determine the association of the biomarkers with the respective outcomes. Receiver operating characteristic curves were used to detect overall predictive accuracy. RESULTS: A total of 222 patients with aSAH were included, of whom 11.71% developed DCI. Most patients with NLR ≥5.9 subsequently died (77 vs. 52%; P = 0.03). DCI was also associated with poor functional outcomes with higher modified Rankin Scale scores (3-6) on discharge (92% vs. 49%; P < 0.01), and longer duration of hospitalization (median, 20 vs. 13 days; P = 0.01). In receiver operating characteristic analyses, the value of RDW was predictive for DCI (area under the curve, 0.70; 95% confidence interval, 0.62-0.79; P < 0.01). The values of NLR (area under the curve, 0.67; 95% CI, 0.59-0.74) potentially predict functional outcome. RDW, NLR, and their combinations were poor discriminators of mortality. CONCLUSIONS: Our study showed that some hematologic parameters analyzed could be of potential value as prognostic biomarkers in patients with aSAH. Hematologic biomarkers are widely available and practical parameters that may be of considerable clinical value in aSAH management, especially in lower-middle-income countries such as the Philippines.
引用
- Ignacio KHD, Diestro JDB, Enriquez CAG, et al. Predictive Value of Hematologic Inflammatory Markers in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2022. PMID: 35017073. doi:10.1016/j.wneu.2022.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。